InvestorsHub Logo
Followers 18
Posts 6761
Boards Moderated 0
Alias Born 03/06/2010

Re: Sankarad1 post# 366847

Monday, 03/07/2022 11:22:59 AM

Monday, March 07, 2022 11:22:59 AM

Post# of 403264
2013 valuation was based on opioid potential. Company had to completely re-engineer itself. Not apples to apples comparison. Elite sold off their opioid like that would have brought in stable and growing revenue over the years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News